History
August 2010
Lumora attracts funding of over £100,000 from the Technology Strategy Board (TSB) to support the company’s development of a rapid sample preparation solution for molecular diagnostics at the point of care.
April 2010
Paul Weinberger joins the Lumora senior management team as CMO.
February 2010
Lumora move to new independent premises on Cambridgeshire business park.
March 2009
Lumora announces the "BART" patent granted in India.
May 2008
Lumora's "BART" patent granted in the US.
April 2008
Ian Johnson joins the Board of Lumora as a non-executive Director.
February 2008
Lumora previews its new hardware system for BART designed to enable molecular diagnostics to be performed at low-cost in challenging settings.
August 2007
Lumora's "BART" patent is granted in the EU.
April 2007
Lumora presents at the 2007 American Association of Clinical Chemists (AACC) annual meeting in St. Louis.
March 2007
Lumora moves to new premises in the Cambridgeshire Business Park, Ely.
January 2007
New Lumora board assembled to implement the development of a rapid molecular test for the food sector.
December 2006
Lumora signs investment deal with Tate & Lyle Ventures.
June 2006
Lumora signs a key licensing deal with the French company bioMérieux.
August 2005
Final investment milestone of the seed funding round successfully achieved.
April 2005
Through the Small Business Research Initiative (SBRI), Lumora has secured funds worth £200k towards the development of a universal, handheld device for the rapid, simultaneous detection of both nucleic acids and small molecules (DNA and proteins) from pathogens in the food supply. Initial targets include E. coli O157:H7, Salmonella enteritidis and bovine tuberculosis.
March 2005
In collaboration with the National Institute of Agriculture and Botany (NIAB), Lumora was awarded a Co-Extra/Framework 6 grant from the European Union to develop a handheld device for the in-the-field tracing of genetically modified crops and foodstuffs which can then be easily adapted toward the diagnosis of plant diseases. Further information.
December 2004
Lumora receives the 'Best New Laboratory Start-up' award from the journal Laboratory News. Further information.
October 2004
Lumora receives a DTI Development Award for £200k towards developing a rapid, point-of-care diagnostic instrument for the detection of Chlamydia trachomatis from urine samples.
July 2004
Lumora receives investment of £250,000 from University Challenge fund in order to commercialise its unique diagnostic technology. Further information.
October 2003
Lumora wins the Pitch Your Idea competition for the best new business concept organised by Biology in Business and sponsored by Cambridge Enterprise and judged by a team of Cambridge biotech entrepreneurs including Dr Andy Richards. Further information.
January 2003
Lumora signs first of a series of collaboration agreements with a major UK government agency leading to contracts worth over £350,000.
October 2002
Lumora is founded by Dr. Laurence Tisi and Prof. Jim Murray to exploit unique intellectual property and expertise in bioluminescence linked to DNA amplification reactions.